We also found that the ratio of miR-195 to BIRC5 in patient tumors is associated with overall survival and recurrence-free survival of lung adenocarcinoma patients, but not lung squamous cell carcinoma patients. This evidence concerns the gene BIRC5 and lung adenocarcinoma.